Details
| Stereochemistry | MIXED |
| Molecular Formula | C20H42O3 |
| Molecular Weight | 330.5457 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 0 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)CCCC(C)CCCC(C)CCCC(C)(O)C(O)CO
InChI
InChIKey=CGIHFIDULQUVJG-UHFFFAOYSA-N
InChI=1S/C20H42O3/c1-16(2)9-6-10-17(3)11-7-12-18(4)13-8-14-20(5,23)19(22)15-21/h16-19,21-23H,6-15H2,1-5H3
| Molecular Formula | C20H42O3 |
| Molecular Weight | 330.5457 |
| Charge | 0 |
| Count |
|
| Stereochemistry | MIXED |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 4 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Phytantriol-based inverted type bicontinuous cubic phase for vascular embolization and drug sustained release. | 2010-12-23 |
|
| The influence of dipalmitoyl phosphatidylserine on phase behaviour of and cellular response to lyotropic liquid crystalline dispersions. | 2010-12 |
|
| High throughput preparation and characterisation of amphiphilic nanostructured nanoparticulate drug delivery vehicles. | 2010-08-16 |
|
| Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water-soluble drugs II. In-vivo evaluation. | 2010-07 |
|
| Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water soluble drugs I. Phase behaviour in physiologically-relevant media. | 2010-07 |
|
| Drug release from lipid liquid crystalline phases: relation with phase behavior. | 2010-04 |
|
| Fragrance material review on 2-hexadecen-1-ol, 3,7,11,15-tetramethyl. | 2010-01 |
|
| Liquid crystalline systems of phytantriol and glyceryl monooleate containing a hydrophilic protein: Characterisation, swelling and release kinetics. | 2009-11 |
|
| Stimuli responsive liquid crystals provide 'on-demand' drug delivery in vitro and in vivo. | 2009-05-05 |
|
| Interaction between lamellar (vesicles) and nonlamellar lipid liquid-crystalline nanoparticles as studied by time-resolved small-angle X-ray diffraction. | 2009-04-07 |
|
| Positron annihilation lifetime spectroscopy (PALS) as a characterization technique for nanostructured self-assembled amphiphile systems. | 2009-01-08 |
|
| Nanostructure of liquid crystalline matrix determines in vitro sustained release and in vivo oral absorption kinetics for hydrophilic model drugs. | 2009-01-05 |
|
| Allergic contact dermatitis to phytantriol. | 2008-10 |
|
| Lipid cubic phases in topical drug delivery: visualization of skin distribution using two-photon microscopy. | 2008-08-07 |
|
| Impurities in commercial phytantriol significantly alter its lyotropic liquid-crystalline phase behavior. | 2008-06-01 |
|
| Thermomyces lanuginosus lipase in the liquid-crystalline phases of aqueous phytantriol: X-ray diffraction and vibrational spectroscopic studies. | 2008-05 |
|
| Aqueous self-assembly of phytantriol in ternary systems: effect of monoolein, distearoylphosphatidylglycerol and three water-miscible solvents. | 2007-11-15 |
|
| Biofunctionalized surfactant mesophases as polyvalent inhibitors of cholera toxin. | 2007-08-25 |
|
| Final report on the safety assessment of phytantriol. | 2007 |
|
| Characterisation of bicontinuous cubic liquid crystalline systems of phytantriol and water using cryo field emission scanning electron microscopy (cryo FESEM). | 2007 |
|
| Bulk and dispersed aqueous phase behavior of phytantriol: effect of vitamin E acetate and F127 polymer on liquid crystal nanostructure. | 2006-11-07 |
|
| Anisotropic surface melting in lyotropic cubic crystals: part 2: facet-by-facet melting at Ia3d/vapor interfaces. | 2006-05 |
|
| Infrared and Raman bands of phytantriol as markers of hydrogen bonding and interchain interaction. | 2005-12 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:51:07 GMT 2025
by
admin
on
Mon Mar 31 18:51:07 GMT 2025
|
| Record UNII |
8LVI07A72W
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
47770
Created by
admin on Mon Mar 31 18:51:07 GMT 2025 , Edited by admin on Mon Mar 31 18:51:07 GMT 2025
|
PRIMARY | |||
|
277-923-2
Created by
admin on Mon Mar 31 18:51:07 GMT 2025 , Edited by admin on Mon Mar 31 18:51:07 GMT 2025
|
PRIMARY | |||
|
Phytantriol
Created by
admin on Mon Mar 31 18:51:07 GMT 2025 , Edited by admin on Mon Mar 31 18:51:07 GMT 2025
|
PRIMARY | |||
|
74563-64-7
Created by
admin on Mon Mar 31 18:51:07 GMT 2025 , Edited by admin on Mon Mar 31 18:51:07 GMT 2025
|
PRIMARY | |||
|
C508873
Created by
admin on Mon Mar 31 18:51:07 GMT 2025 , Edited by admin on Mon Mar 31 18:51:07 GMT 2025
|
PRIMARY | |||
|
DTXSID10868315
Created by
admin on Mon Mar 31 18:51:07 GMT 2025 , Edited by admin on Mon Mar 31 18:51:07 GMT 2025
|
PRIMARY | |||
|
m8768
Created by
admin on Mon Mar 31 18:51:07 GMT 2025 , Edited by admin on Mon Mar 31 18:51:07 GMT 2025
|
PRIMARY | Merck Index | ||
|
8LVI07A72W
Created by
admin on Mon Mar 31 18:51:07 GMT 2025 , Edited by admin on Mon Mar 31 18:51:07 GMT 2025
|
PRIMARY | |||
|
3018525
Created by
admin on Mon Mar 31 18:51:07 GMT 2025 , Edited by admin on Mon Mar 31 18:51:07 GMT 2025
|
PRIMARY | |||
|
8LVI07A72W
Created by
admin on Mon Mar 31 18:51:07 GMT 2025 , Edited by admin on Mon Mar 31 18:51:07 GMT 2025
|
PRIMARY | |||
|
1368211
Created by
admin on Mon Mar 31 18:51:07 GMT 2025 , Edited by admin on Mon Mar 31 18:51:07 GMT 2025
|
PRIMARY |